Filing Details

Accession Number:
0001127602-19-033063
Form Type:
4
Zero Holdings:
No
Publication Time:
2019-11-18 17:31:24
Reporting Period:
2019-11-15
Accepted Time:
2019-11-18 17:31:24
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1613103 Medtronic Plc MDT () 4
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1233311 J Michael Coyle 710 Medtronic Pkwy Ms Lc300
Minneapolis MN 55432
Evp & Group Pres, Cardiac&Vasc No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Ordinary Shares Acquisiton 2019-11-15 36,874 $38.81 225,136 No 4 M Direct
Ordinary Shares Disposition 2019-11-15 7,367 $110.59 217,769 No 4 S Direct
Ordinary Shares Disposition 2019-11-15 25,710 $111.31 192,059 No 4 S Direct
Ordinary Shares Disposition 2019-11-15 3,797 $112.07 188,262 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Ordinary Shares Stock Option (Right to Buy) Disposition 2019-11-15 36,874 $0.00 36,874 $38.81
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
0 2022-07-30 No 4 M Direct
Reported Non-Derivative Holdings
Sec. Name Remaning Holdings Nature of Ownership Explanation
Ordinary Shares 250 Indirect By Family Trust
Ordinary Shares 4,104 Indirect By Spouse
Footnotes
  1. The transactions reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan.
  2. The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $109.96 to $110.96, inclusive. The reporting person undertakes to provide to Medtronic plc , any security holder of Medtronic plc, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes to this Form 4.
  3. The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $110.96 to $111.88, inclusive. The reporting person undertakes to provide to Medtronic plc , any security holder of Medtronic plc, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes to this Form 4.
  4. The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $111.98 to $112.15, inclusive. The reporting person undertakes to provide to Medtronic plc , any security holder of Medtronic plc, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes to this Form 4.
  5. This option to purchase 75,548 New Medtronic ordinary shares for $38.81 per share, which was partially vested at the effective time of the Merger, was received in the Merger and represents the conversion of 75,548 Medtronic common stock shares for $38.81 per share. This New Medtronic stock option has the same terms and conditions as the original Medtronic stock option.